, /PRNewswire/ -- DePuy Synthes Trauma* announced today the U.S. launch of CONFORMFlex with Q-PACKTechnology**, the only pre-hydrated demineralized cancellous bone tissue matrix designed for use in trauma-related extremity procedures (foot and ankle, hand and wrist), including fusion, and for filling bone voids. The announcement was made here at the 2015 Orthopaedic Trauma Association (OTA) Annual Meeting.
About DePuy Synthes Companies
DePuy Synthes Companies of Johnson & Johnson provides the most comprehensive orthopaedic and neurological solutions in the world. The company offers an unparalleled breadth of products, services, programs and research and development capabilities. DePuy Synthes Companies' solutions in the specialties of joint reconstruction, trauma, neurological, craniomaxillofacial, spinal surgery and sports medicine are designed to advance patient care while delivering clinical and economic value to health care systems worldwide. For more information visit, www.depuysynthes.com.
*A division of DePuy Orthopaedics, Inc.
**CONFORM Flex is regulated as an HCT/P (Human Cells, Tissues, and Cellular and Tissue-Based Product); pursuant to 21 CFR 1271.
CONFORM and Q-PACK are registered trademarks of the Musculoskeletal Transplant Foundation.
©DePuy Synthes 2015. All rights reserved. DSUS/BIO/0915/0086
CONFORM with Q-PACK®: An Evaluation of a Pre-Hydrated Fully Demineralized Cancellous Scaffold Seeded with Human Mesenchymal Cells (white paper); Musculoskeletal Transplant Foundation 2011. (00014CI)